Page 2 - Kevinf Mclaughlin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator
Good afternoon, ladies and gentlemen, and welcome to the Acceleron First Quarter 2021 Earnings Conference Call. [Operator Instructions]
I would now like to hand the call over to Ms. Jamie Bernard, Associate Director of Investor Relations at Acceleron. Please go ahead.
Jamie A. Bernard
Associate Director of Investor Relations
Thanks, and welcome, everyone, to our first quarter 2021 earnings call. The press release reporting our financial results in addition to the presentation for today s webcast are available on the Investors & Media page of our corporate website at www.acceleronpharma.com. Joining me on the call this afternoon are Habib Dable, our Chief Executive Officer; Kevin McLaughlin, our Chief Financial Officer; Dr. Jay Backstrom, our Head of Research and Development; Sujay Kango, our Chief Commercial Officer; and Todd James, our Senior Vice President of Corporate Affairs and Investor Relations. As a reminder, we will be making forward-lookin ....

United States , Jamiea Bernard , Jayt Backstrom , Carter Gould , Kevin Mclaughlin , Danielle Brill Raymond James , Kevinf Mclaughlin , Sujay Kango , Carter Gould Barclays , Danielle Brill , Yaron Werber , Todd James , Yaron Werber Cowen , Akash Tewari , Jamie Bernard , Bristol Myer Squibb , Bristol Myers Squibb , Jay Backstrom , Akash Tewari Wolfe Research Analyst , Head Of Research , World Health Organization , Research Development Day , American Thoracic Society International Conference , Wolfe Research , Acceleron Pharma Inc , Corporate Affairs ,